Novartis drug boosted by studies - Irish Times

Novartis drug boosted by studies Irish Times Ilaris, or ACZ885, could become a blockbuster, Trevor Mundel, global head of development at Novartis, said and the drug could go some way to helping Novartis offset patent losses on big sellers, such as blood pressure treatment Diovan. ... and more »